Opko Health Share Price Today
(NASDAQ: OPK)

Name: Opko Health Share Price Today (NASDAQ: OPK) - Opko Health Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Opko Health share price is $1.94 & ₹168.72 as on 6 Mar 2025, 2.30 'hrs' IST

$1.94

▲

0.02

(1.04%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Opko Health share price in Dollar and Rupees. Guide to invest in Opko Health stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Opko Health, along with analyst recommendations, forecasts, and comprehensive financials.

Opko Health share price movements

Today's Low: $1.90
Today's High: $2.03
$1.94
2.06%
Downside
Day's Volatility :6.26%
Upside
4.29%
52 Weeks Low: $0.86
52 Weeks High: $1.94
$1.94
55.66%
Downside
52 Weeks Volatility :55.66%
Upside
0.0%

Opko Health (OPK) Returns

Period	Opko Health, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	22.29%	2.1%	0.0%
6 Months	20.0%	-4.1%	0.0%
1 Year	104.47%	2.2%	0.0%
3 Years	-38.46%	11.8%	-11.6%

Opko Health (OPK) Key Statistics

in dollars & INR

Previous Close	$1.92
Open	$1.93
Today's High	$2.0269
Today's Low	$1.9
Market Capitalization	$1.2B
Today's Volume	$10.3M
52 Week High	$2.0269
52 Week Low	$0.8601
Revenue TTM	$713.1M
EBITDA	$-174.8M
Earnings Per Share (EPS)	$-0.19
Profit Margin	-7.46%
Quarterly Earnings Growth YOY	0.19%
Return On Equity TTM	-3.86%

How to invest in Opko Health Stock (OPK) from India?

It is very easy for Indian residents to invest directly in Opko Health from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Opko Health stock in both Indian Rupees (INR) and US Dollars (USD). Search for Opko Health or OPK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Opko Health or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Opko Health shares which would translate to 0.448 fractional shares of Opko Health as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Opko Health, in just a few clicks!

Returns in Opko Health (OPK) for Indian investors in Rupees

The Opko Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Opko Health investment value today

Current value as on today

₹2,11,346

Returns

₹1,11,346

(+111.35%)

Returns from Opko Health Stock

₹1,06,383 (+106.38%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Opko Health (OPK)

-36%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Opko Health Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Opko Health

Rubric Capital Management LP
7.24%
Vanguard Group Inc
4.34%
BlackRock Inc
4.19%
State Street Corp
1.35%
Geode Capital Management, LLC
1.25%
UBS Group AG
0.72%

Analyst Recommendation on Opko Health

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Opko Health(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Opko Health Stock (OPK)

What analysts predicted

Upside of 104.04%

Target:

$3.96

Current:

$1.94

Insights on Opko Health Stock (Ticker Symbol: OPK)

Price Movement
In the last 7 days, OPK stock has moved up by 15.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 182.18M → 173.63M (in $), with an average decrease of 4.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -81.83M → 24.89M (in $), with an average increase of 417.8% per quarter
OPK vs TMO (3 yr)
In the last 3 years, Opko Health, Inc. has experienced a drawdown of -37.3%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 31.7%

OPK Opko Health Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$901.9M	↓ 8.93%
Net Income	$-312.0M	↑ 103.92%
Net Profit Margin	-34.59%	↓ 19.14%

	FY20	Y/Y Change
Revenue	$1.4B	↑ 59.15%
Net Income	$30.6M	↓ 109.8%
Net Profit Margin	2.13%	↑ 36.72%

	FY21	Y/Y Change
Revenue	$1.8B	↑ 23.64%
Net Income	$-29.5M	↓ 196.45%
Net Profit Margin	-1.66%	↓ 3.79%

	FY22	Y/Y Change
Revenue	$1.0B	↓ 43.42%
Net Income	$-328.0M	↑ 1011.86%
Net Profit Margin	-32.66%	↓ 31.0%

	FY23	Y/Y Change
Revenue	$863.5M	↓ 14.01%
Net Income	$-188.9M	↓ 42.42%
Net Profit Margin	-21.87%	↑ 10.79%

	FY24	Y/Y Change
Revenue	$713.1M	↓ 17.41%
Net Income	$-53.2M	↓ 71.82%
Net Profit Margin	-7.46%	↑ 14.41%

	Q2 FY23	Q/Q Change
Revenue	$265.4M	↑ 11.71%
Net Income	$-19.6M	↑ 7.91%
Net Profit Margin	-7.4%	↑ 0.26%

	Q3 FY23	Q/Q Change
Revenue	$178.6M	↓ 32.71%
Net Income	$-84.5M	↑ 330.24%
Net Profit Margin	-47.31%	↓ 39.91%

	Q4 FY23	Q/Q Change
Revenue	$181.9M	↑ 1.85%
Net Income	$-66.5M	↓ 21.29%
Net Profit Margin	-36.56%	↑ 10.75%

	Q1 FY24	Q/Q Change
Revenue	$173.7M	↓ 4.52%
Net Income	$-81.8M	↑ 23.05%
Net Profit Margin	-47.12%	↓ 10.56%

	Q2 FY24	Q/Q Change
Revenue	$182.2M	↑ 4.89%
Net Income	$-10.3M	↓ 87.41%
Net Profit Margin	-5.66%	↑ 41.46%

	Q3 FY24	Q/Q Change
Revenue	$173.6M	↓ 4.7%
Net Income	$24.9M	↓ 341.53%
Net Profit Margin	14.33%	↑ 19.99%

	FY19	Y/Y Change
Profit	$329.4M	↓ 14.6%

	FY20	Y/Y Change
Profit	$541.0M	↑ 64.24%

	FY21	Y/Y Change
Profit	$581.5M	↑ 7.49%

	FY22	Y/Y Change
Profit	$288.2M	↓ 50.44%

	FY23	Y/Y Change
Profit	$318.1M	↑ 10.38%

	FY24	Y/Y Change
Profit	$311.0M	↓ 2.23%

	Q2 FY23	Q/Q Change
Profit	$126.5M	↑ 27.37%

	Q3 FY23	Q/Q Change
Profit	$47.7M	↓ 62.29%

	Q4 FY23	Q/Q Change
Profit	$23.2M	↓ 51.36%

	Q1 FY24	Q/Q Change
Profit	$20.6M	↓ 11.07%

	Q2 FY24	Q/Q Change
Profit	$31.2M	↑ 51.38%

	Q3 FY24	Q/Q Change
Profit	$40.1M	↑ 28.48%

	FY19	Y/Y Change
Operating Cash Flow	$-172.5M	↑ 58.07%
Investing Cash Flow	$-13.3M	↓ 49.19%
Financing Cash Flow	$175.2M	↑ 24.37%

	FY20	Y/Y Change
Operating Cash Flow	$39.5M	↓ 122.88%
Investing Cash Flow	$-18.3M	↑ 38.11%
Financing Cash Flow	$-35.1M	↓ 120.02%

	FY21	Y/Y Change
Operating Cash Flow	$38.3M	↓ 2.89%
Investing Cash Flow	$35.9M	↓ 296.15%
Financing Cash Flow	$-10.4M	↓ 70.49%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-365.0K	↓ 98.39%
Investing Cash Flow	$-5.5M	↓ 28.85%
Financing Cash Flow	$3.5M	↓ 126.39%

Opko Health Technicals Summary

Sell

Neutral

Buy

Opko Health is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Opko Health (OPK) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Opko Health, Inc.	28.0%	20.0%	104.47%	-38.46%	-13.51%
Agilent Technologies Inc.	-16.31%	-11.06%	-15.84%	-5.59%	73.94%
Idexx Laboratories, Inc.	-5.04%	-5.88%	-20.78%	-14.63%	81.86%
Thermo Fisher Scientific, Inc.	-11.02%	-14.88%	-12.67%	-3.4%	74.9%
Danaher Corp.	-4.23%	-22.21%	-18.58%	-21.71%	45.43%
Iqvia Holdings Inc.	-8.23%	-26.02%	-27.43%	-15.27%	48.04%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Opko Health, Inc.	NA	NA	-2.87	0.0	-0.04	-0.08	NA	2.02
Agilent Technologies Inc.	28.22	28.22	2.06	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	40.97	40.97	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.62	31.62	2.05	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.81	38.81	2.07	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.51	24.51	0.99	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Opko Health, Inc.	Buy	$1.2B	-13.51%	NA	-7.46%
Agilent Technologies Inc.	Buy	$35.1B	73.94%	28.22	19.27%
Idexx Laboratories, Inc.	Buy	$35.6B	81.86%	40.97	22.78%
Thermo Fisher Scientific, Inc.	Buy	$197.5B	74.9%	31.62	14.77%
Danaher Corp.	Buy	$147.0B	45.43%	38.81	16.33%
Iqvia Holdings Inc.	Buy	$32.4B	48.04%	24.51	8.91%

About Opko Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.

Organization	Opko Health
Employees	0
CEO	Dr. Charles W. Bishop
Industry	Health Technology

Management People of Opko Health

Name	Title
Dr. Phillip Frost Ph.D.	Chairman & CEO
Dr. Jane H. Hsiao M.B.A., Ph.D.	Vice Chairman & Chief Technical Officer
Dr. Elias Adam Zerhouni M.D.	President & Vice Chairman
Mr. Adam E. Logal	Senior VP, CFO, Chief Accounting Officer & Treasurer
Mr. Steven D. Rubin Esq., J.D.	Executive VP of Administration & Director
Dr. Akhtar Ashfaq FACP, FASN, M.D.	Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal
Dr. Gary J. Nabel M.D., Ph.D.	Chief Innovation Officer & Director
Mr. Giovanni Abbadessa M.D., Ph.D.	Chief Medical Officer
Dr. Charles W. Bishop	Chief Executive Officer of OPKO Renal
Dr. Antonio F. Cruz	President of Transition Therapeutics

Important FAQs about investing in OPK Stock from India :

What is Opko Health share price today?

Opko Health share price today stands at $1.94, Open: $1.93 ; Previous Close: $1.92 ; High: $2.03 ; Low: $1.90 ; 52 Week High: $1.94 ; 52 Week Low: $0.86.

The stock opens at $1.93, after a previous close of $1.92. The stock reached a daily high of $2.03 and a low of $1.90, with a 52-week high of $1.94 and a 52-week low of $0.86.

Can Indians buy Opko Health shares?

Yes, Indians can invest in the Opko Health (OPK) from India.

With INDmoney, you can buy Opko Health at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Opko Health at zero transaction cost.

How can I buy Opko Health shares from India?

It is very easy to buy Opko Health from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Opko Health (OPK) be purchased?

Yes, you can buy fractional shares of Opko Health with INDmoney app.

What are the documents required to start investing in Opko Health stocks?

To start investing in Opko Health, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.